Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 3,700 shares at $23.75 ($88K) on 2023-02-10, disclosed to the SEC on 2023-02-15.
Open-market sale of $88k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |
| KDNY | SELL | 2022-10-11 | $290K | — | Filing → |